NORCALPHOS- norcalphos injection, solution 
Nova-Tech, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Norcalphos IV

Parenteral Solution

FOR ANIMAL USE ONLY

Contraindications

Do not administer intraperitoneally to horses.

Indications

For intravenous use in milk fever, and in calcium, phosphorus, magnesium and glucose deficiency in animals.

Note

Intravenous administration is always preferable. If used subcutaneously, always distribute dose in several places and massage to facilitate absorption.

Dosage & Administration

Cattle - 500 mL.

For milk fever prophylaxis, give 200-500 mL at time of calving.

Horses - 250-500 mL

Sheep - 50-125 mL

Repeat in 2 to 6 hours if needed.

This product contains no preservative. Unused portion remaining in bottle must be discarded.

Caution

Large doses administered intravenously may have toxic action on heart if the blood level of calcium is raised excessively. Doses should be carefully regulated according to severitity of hypocalcemia and injected slowly so that administration may be stopped if toxic action becomes evident.

KEEP OUT OF REACH OF CHILDREN

CAUTION:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

CONTAINS

Calcium borogluconate, dextrose, magnesium borogluconate, calcium hypophosphite and base.

Total calcium chemically equivalent to calcium borogluconate .......................................... 26.0% w/v

Dextrose • H2O ......................................................................................................... 15.0% w/v

Magnesium Borogluconate ............................................................................................ 6.0% w/v

Total phosphorus in amounts chemically equivalent to elemental phosphorus ...................... 0.5% w/v

Store between 15°C-30°C (59°F-86°F).

TAKE TIME OBSERVE LABEL DIRECTIONS

Manufactured by:

Nova-Tech, Inc.

Grand Island, NE 68801 USA

18-811

RMS 92-340

NDC# 65207-811-50

Net Contents:

500 mL (16.91 fl oz)

Assembled in USA

Lot No.

Exp. Date

500 mL label

NORCALPHOS 
norcalphos injection, solution
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:65207-811
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Calcium Borogluconate (UNII: 6915G2PQI0) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CATION26 g  in 100 mL
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE15 g  in 100 mL
MAGNESIUM GLUCONATE (UNII: T42NAD2KHC) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM GLUCONATE6 g  in 100 mL
Phosphorus (UNII: 27YLU75U4W) (PHOSPHORUS - UNII:27YLU75U4W) Phosphorus0.5 g  in 100 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:65207-811-50500 mL in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/22/2019
Labeler - Nova-Tech, Inc. (196078976)
Registrant - Nova-Tech, Inc. (196078976)
Establishment
NameAddressID/FEIBusiness Operations
Nova-Tech, Inc.196078976manufacture, api manufacture, analysis
Establishment
NameAddressID/FEIBusiness Operations
Zhejiang Ruibang Laboratories544807456api manufacture

Revised: 2/2023
Document Id: e551c499-ef5a-47da-9134-bf080bee5948
Set id: 83e4f515-72fe-4b54-8b7b-4a96e667b257
Version: 2
Effective Time: 20230208
 
Nova-Tech, Inc.